Recent News for TGTX - TG Therapeutics, Inc.

Date Title
Apr 15 TG Therapeutics: 2020 Offers Investors A Cascade Of Clinical And Regulatory Catalysts
Mar 25 TG Therapeutics (TGTX) Upgraded to Buy: What Does It Mean for the Stock?
Mar 23 Edited Transcript of TGTX earnings conference call or presentation 3-Mar-20 1:00pm GMT
Mar 22 Did You Manage To Avoid TG Therapeutics's (NASDAQ:TGTX) Painful 52% Share Price Drop?
Mar 9 TG Therapeutics Announces Data Presentations at the Upcoming American Academy of Neurology 72nd Annual Meeting
Mar 5 TG Therapeutics Receives Orphan Drug Designation for Umbralisib from the U.S. Food and Drug Administration for the Treatment of Follicular Lymphoma
Mar 3 TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2019 Results - Earnings Call Transcript
Mar 3 TG Therapeutics net loss improves in Q4
Mar 3 TG Therapeutics EPS misses by $0.02
Mar 3 TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2019 Financial Results
Feb 29 The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
Feb 28 TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2019 Financial Results and Business Update
Feb 26 44 Stocks Moving in Wednesday's Pre-Market Session
Feb 24 TG Therapeutics Edges Closer To Commercialization And Potential Share Price Gain
Feb 21 TG Therapeutics: More Catalysts Unlocking
Jan 21 TG Therapeutics, Inc. (NASDAQ:TGTX) Insiders Increased Their Holdings
Jan 17 The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
Jan 16 ACB, MS among premarket gainers
Jan 16 TG Therapeutics initiates umbralisib application in U.S.
Jan 16 TG Therapeutics Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma or Follicular Lymphoma
Jan 16 The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
Jan 10 Options Traders Expect Huge Moves in TG Therapeutics (TGTX) Stock
Jan 10 TG Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
Jan 9 The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results
Dec 27 31 Healthcare Stocks Moving In Friday's Pre-Market Session

Back to the Main TGTX Page...